Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 11;139(40):14077-14089.
doi: 10.1021/jacs.7b04690. Epub 2017 Sep 28.

Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators

Affiliations

Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators

Christopher D McCune et al. J Am Chem Soc. .

Abstract

Developing specific chemical functionalities to deploy in biological environments for targeted enzyme inactivation lies at the heart of mechanism-based inhibitor development but also is central to other protein-tagging methods in modern chemical biology including activity-based protein profiling and proteolysis-targeting chimeras. We describe here a previously unknown class of potential PLP enzyme inactivators; namely, a family of quaternary, α-(1'-fluoro)vinyl amino acids, bearing the side chains of the cognate amino acids. These are obtained by the capture of suitably protected amino acid enolates with β,β-difluorovinyl phenyl sulfone, a new (1'-fluoro)vinyl cation equivalent, and an electrophile that previously eluded synthesis, capture and characterization. A significant variety of biologically relevant AA side chains are tolerated including those for alanine, valine, leucine, methionine, lysine, phenylalanine, tyrosine, and tryptophan. Following addition/elimination, the resulting transoid α-(1'-fluoro)-β-(phenylsulfonyl)vinyl AA-esters undergo smooth sulfone-stannane interchange to stereoselectively give the corresponding transoid α-(1'-fluoro)-β-(tributylstannyl)vinyl AA-esters. Protodestannylation and global deprotection then yield these sterically encumbered and densely functionalized quaternary amino acids. The α-(1'-fluoro)vinyl trigger, a potential allene-generating functionality originally proposed by Abeles, is now available in a quaternary AA context for the first time. In an initial test of this new inhibitor class, α-(1'-fluoro)vinyllysine is seen to act as a time-dependent, irreversible inactivator of lysine decarboxylase from Hafnia alvei. The enantiomers of the inhibitor could be resolved, and each is seen to give time-dependent inactivation with this enzyme. Kitz-Wilson analysis reveals similar inactivation parameters for the two antipodes, L-α-(1'-fluoro)vinyllysine (Ki = 630 ± 20 μM; t1/2 = 2.8 min) and D-α-(1'-fluoro)vinyllysine (Ki = 470 ± 30 μM; t1/2 = 3.6 min). The stage is now set for exploration of the efficacy of this trigger in other PLP-enzyme active sites.

PubMed Disclaimer

Conflict of interest statement

Notes The authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Potential PLP-enzyme inactivation mechanisms for quaternary, α-(1′-fluoro)vinyl amino acids, following the design of Abeles for α-(1′-fluoro)vinylglycine, illustrated for an AADC mechanism, highlighting both γ-conjugate addition (via an alleneimine intermediate) and β-conjugate addition (both via an alleneimine and via γ-protonation) pathways.
Figure 2
Figure 2
A-Synthesis of β,β-difluorovinyl phenyl sulfone 5 which following Kuglerohr distillation is isolated as a transparent oil. B-1H NMR spectrum of 5 after purification; reaction run for 20 s. C-13C NMR spectrum of 5 showing both geminal and vicinal C–F splitting.
Figure 3
Figure 3
A-Schematic representation of the 14CO2-capture assay employed for LDC activity. LDC from Hafnia alvei was incubated with U-C-labeled L-lysine (2.5 mM conc; 7.14 nCi in 200 μL total volume) in an Eppendorf tube. Evolved 14CO2 was captured with base (benzethonium hydroxide) soaked filter paper… B-Schematic of the complementary UV-based Lenhoff assay that measures formation of cadaverine product with time (details in the SI). C-Primary and secondary Kitz-Wilson plots for the time dependent inactivation of H. alvei LDC by L- and D-α-(1′-fluoro)vinyllysine. D-Results of dialysis experiments. LDC (1.5 U) was first inactivated for 1 h with 10 mM (±)-α-(1′-fluoro)vinyllysine (98.9% inactivation). Each cycle was run as a 1:250-fold dilution against 100 μM PLP, 100 mM KPO4, pH 6.0. A total of 9 cycles of dialysis (~1021-fold dilution) was run. The insert (lower right corner) shows an expansion of the cpm vs. time data for the inactivated enzyme samples as a function of dialysis cycle.
Scheme 1
Scheme 1. Toward Quaternary, Fluorovinyl Amino Acids
A – Quaternary, α-(2′Z-fluoro)vinyl AAs via excision/(2-fluoro)methylenation of α-vinyl AAs B – Quaternary, α-(1′-fluoro)vinyl AAs via convergent, α-(1-fluoro)vinylation of AA-enolates
Scheme 2
Scheme 2
Double Add’n/Elimination with AA-Derived Dianions
Scheme 3
Scheme 3
Single vs. Double Addition/Elimination
Scheme 4
Scheme 4
α-(1′-Fluoro)vinylation of AA-Derived Enolates with 5
Scheme 5
Scheme 5
α-Fluoro Sulfone-Stannane Interchange: Entry into Quaternary, Fluoro-Trialkylstannylvinyl AAs
Scheme 6
Scheme 6
Global Deprotection to Quaterary, α-(1′-Fluoro)vinyl AAs a – In these cases, though the fluorovinyl AA-HCl salt was clean by NMR, we elected to generate the free, quaternary, α-(1′-fluoro)vinyl AA via ion exchange chromatography [Dowex-50; 96% from 11a-HCl; (Ala); 94% from 11e-HCl (Met)]. b – In this case, Dowex 50 cation exchange chromatography also led to an improvement in purity (~15%, by NMR) of the fluorovinyl AA (76% from 11f-HCl). c – In this case, MOM cleavage was performed with TFA in CH2Cl2, with accompanying protodestannylation and aldimine cleavage, followed by via base-catalyzed ester saponification. The crude product was acidified and purified via Dowex 50 cation exchange chromatography (66% yield of 11h).

Similar articles

Cited by

References

    1. Chen YC, Backus KM, Merkulova M, Yang C, Brown D, Cravatt BF, Zhang C. J Am Chem Soc. 2017;139:639–642. - PMC - PubMed
    2. Seki H, Xue S, Pellett S, Silhar P, Johnson EA, Janda KD. J Am Chem Soc. 2016;138:5568–5575. - PMC - PubMed
    3. Malcomson T, Yelekci K, Borrello MT, Ganesan A, Semina E, De Kimpe N, Mangelinckx S, Ramsay RR. FEBS J. 2015;282:3190–8. - PubMed
    4. Beahm BJ, Dehnert KW, Derr NL, Kuhn J, Eberhart JK, Spillmann D, Amacher SL, Bertozzi CR. Angew Chem Int Ed. 2014;53:3347–3352. - PMC - PubMed
    5. Lange S, Rocha-Ferreira E, Thei L, Mawjee P, Bennett K, Thompson PR, Subramanian V, Nicholas AP, Peebles D, Hristova M, Raivich G. J Neurochem. 2014;130:555–562. - PMC - PubMed
    6. Paul B, Das D, Ellington B, Marsh ENG. J Am Chem Soc. 2013;135:5234–5237. - PMC - PubMed
    7. Fuhrmann J, Subramanian V, Thompson PR. ACS Chem Biol. 2013;8:2024–2032. - PubMed
    8. Seeliger JC, Holsclaw CM, Schelle MW, Botyanszki Z, Gilmore SA, Tully SE, Niederweis M, Cravatt BF, Leary JA, Bertozzi CR. J Biol Chem. 2012;287:7990–8000. - PMC - PubMed
    9. Huang H, Chang Wc, Pai PJ, Romo A, Mansoorabadi SO, Russell DH, Liu Hw. J Am Chem Soc. 2012;134:16171–16174. - PMC - PubMed
    10. Shi C, Geders TW, Park SW, Wilson DJ, Boshoff HI, Abayomi O, Barry CE, Schnappinger D, Finzel BC, Aldrich CC. J Am Chem Soc. 2011;133:18194–18201. - PMC - PubMed
    11. Culhane JC, Wang D, Yen PM, Cole PA. J Am Chem Soc. 2010;132:3164. - PMC - PubMed
    1. Schirmeister T, Kesselring J, Jung S, Schneider TH, Weickert A, Becker J, Lee W, Bamberger D, Wich PR, Distler U, Tenzer S, Johe P, Hellmich UA, Engels B. J Am Chem Soc. 2016;138:8332–8335. - PubMed
    2. London N, Miller RM, Krishnan S, Uchida K, Irwin JJ, Eidam O, Gibold L, Cimermancic P, Bonnet R, Shoichet BK, Taunton J. Nat Chem Biol. 2014;10:1066–1072. - PMC - PubMed
    3. Noe MC, Gilbert AM. Ann Rep Med Chem. 2012;47:413–439.
    4. Singh J, Petter RC, Kluge AF. Curr Opin Chem Biol. 2010;14:475–480. - PubMed
    5. Smith AJT, Zhang X, Leach AG, Houk KN. J Med Chem. 2009;52:225–233. - PMC - PubMed
    1. McCune CD, Chan SJ, Beio ML, Shen W, Chung WJ, Szczesniak LM, Chai C, Koh SQ, Wong PTH, Berkowitz DB. ACS Cent Sci. 2016;2:242–252. - PMC - PubMed
    1. Bauer RA. Drug Discovery Today. 2015;20:1061–1073. - PubMed
    1. Singh J, Petter RC, Baillie TA, Whitty A. Nat Rev Drug Discovery. 2011;10:307–317. - PubMed

Publication types

MeSH terms